SAIPH Laboratories
Multi-site pharmaceutical group manufacturing human medicines across five GMP-certified production facilities.
SAIPH (Societe Arabe des Industries Pharmaceutiques) manufactures and markets prescription and OTC medicines for human use from five GMP-certified production sites employing over 600 people. The company supplies the Tunisian public health system and exports to North Africa and sub-Saharan Africa.
- Type
- Manufacturer
- Location
- Tunis, Tunisia
- Founded
- 1992
- Website
- https://www.saiph.com.tn
- Categories
- Medical & Healthcare Supplies
- Markets
- Tunisia, Algeria, Libya, Morocco, Senegal
Verified facts
- web-presence-since (green), checked 2026-08-04 Internet Archive (Wayback)
- sanctions-clear (green), checked 2026-08-12 OpenSanctions
- debarment-clear (green), checked 2026-08-12 OpenSanctions
Claimed certifications
- Good Manufacturing Practice
- ISO 9001, Quality Management IAF CertSearch
Import rules for these goods
- Medical devices sold in the EU must carry CE marking under the Medical Device Regulation (EU) 2017/745, with a conformity assessment matched to the device risk class. European Commission (MDR)
- For the US market, the maker must have an FDA device establishment registration and product listing; most instruments also need 510(k) premarket clearance. US FDA (devices)